Nervous System News and Research

Latest Nervous System News and Research

Mutated TDP-43 can cause neurons to die: Study

Lou Gehrig's disease, or amyotrophic lateral sclerosis, and frontotemporal lobar degeneration are characterized by protein clumps in brain and spinal-cord cells that include an RNA-binding protein called TDP-43. This protein is the major building block of the lesions formed by these clumps.

6 Jan 2011

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Genentech, Inc., a member of the Roche Group, today announced that the United States Food and Drug Administration has extended the ACTEMRA (tocilizumab, RoACTEMRA in the European Union) label to include inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult patients with moderately to severely active rheumatoid arthritis, when given in combination with methotrexate.

6 Jan 2011

Researchers say women with multiple sclerosis have more HLA genes than men

Women who have multiple sclerosis (MS) are more likely to have a gene associated with multiple sclerosis than men with the disease and it is this gene region where environment interacts with the genetics, according to a study published in the January 5, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.

6 Jan 2011

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros Corporation (Nasdaq: OMER) today announced that it has obtained an exclusive license from The Regents of the University of California to a new series of antifibrinolytic agents. These optimized agents represent a significant potential advance in the control of surgical and traumatic bleeding.

6 Jan 2011

New laboratory manual on imaging in developmental biology

Imaging technologies have revolutionized the study of developmental biology and are now essential tools for researchers in the field. A newly released laboratory manual, Imaging in Developmental Biology, presents a comprehensive set of visualization methods specifically for developmental biologists. It is the newest volume in a series of imaging manuals published by Cold Spring Harbor Laboratory Press.

5 Jan 2011

Depression and diabetes linked to increased risk of death from heart disease in women

Depression and diabetes appear to be associated with a significantly increased risk of death from heart disease and risk of death from all causes over a six-year period for women, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jan 2011

Diamyd Medical publishes change in total number of votes and shares

As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).

30 Dec 2010

Clinical Data closes sale of genetic, pharmacogenomic testing and biomarker development business

Clinical Data, Inc. today announced that the Company has closed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic, Inc. for $15.5 million. The sale completes Clinical Data's transformation into a pharmaceutical company with a deep product pipeline, including two promising late-stage compounds, the most advanced of which is vilazodone, a new treatment in development for Major Depressive Disorder.

30 Dec 2010

Positive results from OMS201 Phase 1/2 trial in patients undergoing urologic procedures

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of OMS201, the Company's urological PharmacoSurgery™ product candidate.

29 Dec 2010

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.

29 Dec 2010

Study reports ROP18 protein protects parasite in host cell

Researchers at Washington University School of Medicine in St. Louis have learned why changes in a single gene, ROP18, contribute substantially to dangerous forms of the parasite Toxoplasma gondii. The answer has likely moved science a step closer to new ways to beat Toxoplasma and many other parasites.

28 Dec 2010

Epilepsy not getting the public attention and research funding it deserves

Epilepsy, a common and serious neurologic disorder that affects millions of people, is not getting the public attention and funding for research it deserves, according to an editorial on a study published in the January 4, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.

28 Dec 2010

RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

RegeneRx Biopharmaceuticals, Inc. announced today that beginning with the opening of trading on December 23, 2010, the Company's common stock is expected to be quoted on the OTC Bulletin Board under the symbol RGRX following its suspension from the NYSE Amex as of that date.

24 Dec 2010

MiMedx receives notification of Class III certification for HydroFix technology

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification of the Class III certification for a European product using the Company's proprietary HydroFix technology.

24 Dec 2010

Zogenix announces underwriters partial exercise of over-allotment option in initial public offering

Zogenix, Inc. announced today that the underwriters of its recently completed initial public offering of common stock have partially exercised their option to purchase shares of common stock from Zogenix to cover over-allotments. The sale of additional shares is expected to close on December 27, 2010.

23 Dec 2010

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Janssen Inc. has filed a New Drug Submission (NDS) to Health Canada for the investigational drug abiraterone acetate administered with prednisone for the treatment of metastatic, advanced prostate cancer in patients who have received prior chemotherapy containing a taxane. Submissions for abiraterone acetate have also been filed with health authorities in the United States and Europe.

23 Dec 2010

Santen files IND for Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension

Clinical Data, Inc., today announced that Santen Pharmaceutical Co., Ltd., has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for Clinical Data's highly selective adenosine A2A agonist, ATL313, for the indication of primary open angle glaucoma and ocular hypertension.

From Santen Pharmaceutical Co., Ltd. 23 Dec 2010

Fried fish consumption may increase risk of stroke

People living in the "stroke belt" states eat more fried fish than people living in the rest of the country, which may contribute to the high rate of death from stroke in those states, according to a study published in the December 22, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

23 Dec 2010

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

Male mice created without Y chromosome

University of Adelaide researchers are a step closer to unraveling the mysteries of human sexual development, following genetic studies that show male mice can be created without a Y chromosome - through the activation of an ancient brain gene.

23 Dec 2010

Nervous System News and Research

Latest Nervous System News and Research

Mutated TDP-43 can cause neurons to die: Study

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Researchers say women with multiple sclerosis have more HLA genes than men

Omeros receives exclusive license for new series of antifibrinolytic agents

New laboratory manual on imaging in developmental biology

Depression and diabetes linked to increased risk of death from heart disease in women

Diamyd Medical publishes change in total number of votes and shares

Clinical Data closes sale of genetic, pharmacogenomic testing and biomarker development business

Positive results from OMS201 Phase 1/2 trial in patients undergoing urologic procedures

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Study reports ROP18 protein protects parasite in host cell

Epilepsy not getting the public attention and research funding it deserves

RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

MiMedx receives notification of Class III certification for HydroFix technology

Zogenix announces underwriters partial exercise of over-allotment option in initial public offering

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Santen files IND for Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension

Fried fish consumption may increase risk of stroke

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Male mice created without Y chromosome

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Nervous System News and Research

Latest Nervous System News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in